Loading clinical trials...
Loading clinical trials...
The purpose of this study is to observe the safety and effectiveness of the AMPLATZER™ Cardiac Plug (ACP) device in Chinese population indicated for use of AMPLATZER™ Cardiac Plug after its market app...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Abbott Medical Devices
NCT05232643 · Non-Valvular Atrial Fibrillation (NVAF)
NCT06606275 · End-Stage Kidney Disease (ESKD), Non-valvular Atrial Fibrillation (NVAF), and more
NCT05022758 · Non-valvular Atrial Fibrillation (NVAF)
The First Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong
Sir Run Run Shaw Hospital
Zhejiang, Hangzhou
Wuhan Asia Heart Hospital
Wuhan, Hubei
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions